Halozyme Therapeutics HALO Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Halozyme Therapeutics’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's earnings yield?
- Halozyme Therapeutics (HALO) reported earnings yield of 6.9% in Q3 2025.
- How has Halozyme Therapeutics's earnings yield changed year-over-year?
- Halozyme Therapeutics's earnings yield increased by 28.7% year-over-year, from 5.4% to 6.9%.
- What is the long-term trend for Halozyme Therapeutics's earnings yield?
- Over 4 years (2020 to 2024), Halozyme Therapeutics's earnings yield has grown at a 35.1% compound annual growth rate (CAGR), from 2.2% to 7.3%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.